Drake CG - Search Results

1

TGM4: an immunogenic prostate-restricted antigen.

Lopez-Bujanda ZA, Obradovic A, Nirschl TR, Crowley L, Macedo R, Papachristodoulou A, O'Donnell T, Laserson U, Zarif JC, Reshef R, Yuan T, Soni MK, Antonarakis ES, Haffner MC, Larman HB, Shen MM, Muranski P, Drake CG. Lopez-Bujanda ZA, et al. Among authors: drake cg. J Immunother Cancer. 2021 Jun;9(6):e001649. doi: 10.1136/jitc-2020-001649. J Immunother Cancer. 2021. PMID: 34193566 Free PMC article.

2

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.

Drake CG, Doody AD, Mihalyo MA, Huang CT, Kelleher E, Ravi S, Hipkiss EL, Flies DB, Kennedy EP, Long M, McGary PW, Coryell L, Nelson WG, Pardoll DM, Adler AJ. Drake CG, et al. Cancer Cell. 2005 Mar;7(3):239-49. doi: 10.1016/j.ccr.2005.01.027. Cancer Cell. 2005. PMID: 15766662 Free PMC article.

3

Immunotherapy for metastatic prostate cancer.

Drake CG. Drake CG. Urol Oncol. 2008 Jul-Aug;26(4):438-44. doi: 10.1016/j.urolonc.2007.03.029. Epub 2007 Dec 21. Urol Oncol. 2008. PMID: 18593624 Free PMC article. Review.

4

Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Wada S, Yoshimura K, Hipkiss EL, Harris TJ, Yen HR, Goldberg MV, Grosso JF, Getnet D, Demarzo AM, Netto GJ, Anders R, Pardoll DM, Drake CG. Wada S, et al. Among authors: drake cg. Cancer Res. 2009 May 15;69(10):4309-18. doi: 10.1158/0008-5472.CAN-08-4102. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435909 Free PMC article.

5

Current status of immunological therapies for prostate cancer.

Antonarakis ES, Drake CG. Antonarakis ES, et al. Among authors: drake cg. Curr Opin Urol. 2010 May;20(3):241-6. doi: 10.1097/MOU.0b013e3283381793. Curr Opin Urol. 2010. PMID: 20179598 Free PMC article. Review.

6

Update: immunological strategies for prostate cancer.

Drake CG, Antonarakis ES. Drake CG, et al. Curr Urol Rep. 2010 May;11(3):202-7. doi: 10.1007/s11934-010-0106-8. Curr Urol Rep. 2010. PMID: 20425628 Free PMC article. Review.

7

Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study.

Keizman D, Zahurak M, Sinibaldi V, Carducci M, Denmeade S, Drake C, Pili R, Antonarakis ES, Hudock S, Eisenberger M. Keizman D, et al. Clin Cancer Res. 2010 Nov 1;16(21):5269-76. doi: 10.1158/1078-0432.CCR-10-1928. Epub 2010 Oct 26. Clin Cancer Res. 2010. PMID: 20978144 Free PMC article. Clinical Trial.

8

Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.

Zabransky DJ, Smith HA, Thoburn CJ, Zahurak M, Keizman D, Carducci M, Eisenberger MA, McNeel DG, Drake CG, Antonarakis ES. Zabransky DJ, et al. Among authors: drake cg. Prostate. 2012 Apr;72(5):487-98. doi: 10.1002/pros.21449. Epub 2011 Jul 11. Prostate. 2012. PMID: 21748755 Free PMC article. Clinical Trial.

9

Current status of immunological approaches for the treatment of prostate cancer.

Drake CG, Antonarakis ES. Drake CG, et al. Curr Opin Urol. 2012 May;22(3):197-202. doi: 10.1097/MOU.0b013e3283519ad5. Curr Opin Urol. 2012. PMID: 22328018 Free PMC article. Review.

10

Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy.

Antonarakis ES, Drake CG. Antonarakis ES, et al. Among authors: drake cg. Curr Opin Oncol. 2012 May;24(3):258-65. doi: 10.1097/CCO.0b013e32835205a0. Curr Opin Oncol. 2012. PMID: 22410456 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters